Sigyn Therapeutics SIGY
OTC SIGY
$0.03 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Sigyn Therapeutics (SIGY) Divestments (2019)

Sigyn Therapeutics' (SIGY) quarterly Divestments came in at $100000.0 in Q1 2019.

Analysis

Sigyn Therapeutics (SIGY) Divestments (2019) Analysis & Trends

Sigyn Therapeutics has disclosed Divestments across 1 years of filings, most recently posting $100000.0 for Q1 2019.

  • In Q1 2019, Divestments changed N/A year-over-year to $100000.0; the TTM figure through Dec 2019 stood at $100000.0 (changed N/A YoY), while the FY2019 annual figure was $100000.0, changed N/A from the prior year.
  • Divestments came in at $100000.0 for Q1 2019 at Sigyn Therapeutics.
  • In the past five years, Divestments ranged from a high of $100000.0 in Q1 2019 to a low of $100000.0 in Q1 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn -
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn -
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn -
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -
10 Sigyn Therapeutics 48,161.31 -37,409.69 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 100,000.00